Washington: A American bio-tech company Moderna Inc that its experimental vaccine is 94.5% effective in preventing Covid-19 based on Interim data from a late-stage clinical trial buoyed the mood. In US even as a pandemic surged to record levels across a country that is politically divided, among other issues, on the approach to the pandemic.

The Moderna Inc announced about the vaccine on Monday. Moderna’s break through, coming on top of a similar announcement by Pfizer last week, and more success expected from atleast 10 other drug companies, means the US and the world could be on track to checkmate the pandemic in 2021 regardless of politics.

Moderna is expected to file for emergency use authorization after submitting safety data in next few days. The FDA has said vaccines should be atleast 50% effective to be approved, and matrics disclosed by Moderna and Pfizer beat that comfortably. Some experts cautioned that claims from both Moderna and Pfizer have not been evaluated in peer-reviewed scientific generals.